# The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, Paragraph 2: Amendment of the Access to Medical Treatments (Innovation) Act 2016

Extent: E+W+S+N.I.

In section 3(2)(b) and (4)(a), (b) and (c) of the Access to Medical Treatments (Innovation) Act 2016 (provision supplementary to section 2: database of innovative treatments) insert “ UK ” before “marketing authorisation”.

---
Source: https://www.legislation.gov.uk/uksi/2019/775/schedule/8/paragraph/2 (the official version)
Page: https://openlegislation.uk/human-medicines-amendment-etc-eu-exit-regulations-2019/schedule-8/paragraph-2
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.